First page Back Continue Last page Overview Text

Notes:


http://www.vitaletherapeutics.org/vtlcsmal.htm

Comparing vitalethine's immune support, alone and with a bolus of dead cancer cells, makes clear that dead cancer cells diminish chances of long-term survival. Responses at high doses.do not translate into long-term survival. Low doses of up to 10fg/kg are far more effective long-term, but poisoning of immune support with dead cancer cell membranes suggests that environmental challenges become more profound at close to threshold doses (~3 fg/kg) for response to natural vitalethine. This threshold is flanked on either side by concentrations of plutonium and aflatoxin that cause cancer. Chemotherapy and radiation kill cancer, but leave the dead cells in the body to rot, which complicates therapy and spreads the environment challenges that caused the cancer.